Literature DB >> 26988389

Antipsychotic use in dementia patients in a general practice setting: a Dutch population-based study.

J Sultana1, I Leal2, M de Ridder2, M Sturkenboom2, G Trifiró1.   

Abstract

Entities:  

Keywords:  Antipsychotics; Netherlands; dementia; healthcare database

Mesh：

Substances：

Year:  2016        PMID： 26988389      PMCID： PMC7137605          DOI： 10.1017/S2045796016000111

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN： 2045-7960            Impact factor:   6.892


× No keyword cloud information.
  17 in total

1.  Changes in trend of antipsychotics prescription in patients treated with cholinesterase inhibitors after warnings from Italian Medicines Agency. Results from the EPIFARM-Elderly Project.

Authors:  Carlotta Franchi; Mauro Tettamanti; Alessandra Marengoni; Francesca Bonometti; Luca Pasina; Laura Cortesi; Ida Fortino; Angela Bortolotti; Luca Merlino; Ugo Lucca; Emma Riva; Alessandro Nobili
Journal:  Eur Neuropsychopharmacol       Date:  2012-01-31       Impact factor: 4.600

2.  Risk of cerebrovascular events in elderly users of antipsychotics.

Authors:  B C Kleijer; R J van Marum; A C G Egberts; P A F Jansen; W Knol; E R Heerdink
Journal:  J Psychopharmacol       Date:  2008-07-17       Impact factor: 4.153

3.  Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings.

Authors:  Adeline Gallini; Sandrine Andrieu; Julie M Donohue; Naïma Oumouhou; Maryse Lapeyre-Mestre; Virginie Gardette
Journal:  Eur Neuropsychopharmacol       Date:  2013-09-17       Impact factor: 4.600

4.  Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain.

Authors:  Gabriel Sanfélix-Gimeno; Pedro Cervera-Casino; Salvador Peiró; Beatriz González López-Valcarcel; Amparo Blázquez; Teresa Barbera
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 5.  Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel.

Authors:  Helen C Kales; Laura N Gitlin; Constantine G Lyketsos
Journal:  J Am Geriatr Soc       Date:  2014-03-17       Impact factor: 5.562

6.  Antipsychotic drug prescription rates among Dutch nursing homes: the influence of patient characteristics and the dementia special care unit.

Authors:  M J G van der Putten; R B Wetzels; H Bor; S U Zuidema; R T C M Koopmans
Journal:  Aging Ment Health       Date:  2014-02-10       Impact factor: 3.658

7.  Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study.

Authors:  Gianluca Trifirò; Giovanni Gambassi; Elif F Sen; Achille P Caputi; Vincenzo Bagnardi; Jose Brea; Miriam C J M Sturkenboom
Journal:  Ann Intern Med       Date:  2010-04-06       Impact factor: 25.391

8.  Variability between nursing homes in prevalence of antipsychotic use in patients with dementia.

Authors:  Bart C Kleijer; Rob J van Marum; Dinnus H M Frijters; Paul A F Jansen; Miel W Ribbe; Antoine C G Egberts; Eibert R Heerdink
Journal:  Int Psychogeriatr       Date:  2013-11-20       Impact factor: 3.878

9.  All-cause mortality associated with atypical and typical antipsychotics in demented outpatients.

Authors:  Gianluca Trifirò; Katia M C Verhamme; Gijsbertus Ziere; Achille P Caputi; Bruno H Ch Stricker; Miriam C J M Sturkenboom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-05       Impact factor: 2.890

10.  PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol.

Authors:  Klaas van der Spek; Debby L Gerritsen; Martin Smalbrugge; Marjorie H J M G Nelissen-Vrancken; Roland B Wetzels; Claudia H W Smeets; Sytse U Zuidema; Raymond T C M Koopmans
Journal:  BMC Psychiatry       Date:  2013-11-15       Impact factor: 3.630
View more
  1 in total

1.  Identifying Data Elements to Measure Frailty in a Dutch Nationwide Electronic Medical Record Database for Use in Postmarketing Safety Evaluation: An Exploratory Study.

Authors:  Janet Sultana; Ingrid Leal; Marcel de Wilde; Maria de Ridder; Johan van der Lei; Miriam Sturkenboom; Gianluca Trifiro'
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.